caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1356635627

Lyndsey Stuerman

Nurse PractitionerKremmling, COI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Lyndsey Stuerman's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 3 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Rachel Scott
Nurse Practitioner · Kremmling, CO
1658
GUTIERREZ, GREG1326
Jason Stuerman
Family Practice · Granby, CO
1231
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
KREMMLING MEMORIAL HOSPITAL DISTRICT64656
Rachel Scott
Nurse Practitioner · Kremmling, CO
1439
Jason Stuerman
Family Practice · Granby, CO
1240
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
308
Beneficiaries
—
Total drug cost
$2K
Distinct drugs
13
Brand share
6.5%
Top prescribed drugs
Atorvastatin Calcium55 claims
Levothyroxine Sodium44 claims
Metformin Hcl28 claims
Amlodipine Besylate26 claims
Omeprazole22 claims
QUALITY · MIPS · 2024
Final MIPS score
73.6
Quality
76.8
Cost
35.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
-0.17%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.